Insiders · Profile

Lewis Tanya

Chief Dev. Op. Officer at Replimune · EVP, Chief Reg. Affairs at Karyopharm Therapeutics. Filing since 30 Oct 2020. CIK 0001451038

Company

Date

Role

Action

Amount

Of holding

13 Jun 2023

Chief Dev. Op. Officer

Sold on a plan

12,860

$309.39K

8.7%

16 May 2023

Chief Dev. Op. Officer

Sold at will

12,207

$220.34K

7.6%

16 May 2022

Chief Dev. Op Officer

Sold, plan not stated

5,473

$79.85K

4.3%

11 Feb 2021

EVP, Chief Reg. Affairs

Sold, plan not stated

2,046

$31.75K

33.1%

30 Oct 2020

EVP,Chief Reg.&Quality Officer

Sold, plan not stated

226

$3.52K

29.5%

5 decisions on file.